Skip to content
WeighLab

Alloy vs Knownwell

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Alloy

Provider comparison

Women who want menopause care and GLP-1 weight management under the same physician and don't mind a recurring care fee.

Semaglutide / month
$169/moStarting dose, compounded
Tirzepatide / month
$199/moStarting dose, compounded
Index 77/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check Alloy pricing Read review

Knownwell

Provider comparison

Insured shoppers who want an obesity-medicine specialist overseeing brand-name GLP-1 care, with published self-pay drug prices as a fallback.

Semaglutide / month
$149/moBrand Wegovy pill, 1.5 mg starting dose, visits billed separately; Wegovy pen $349/mo, new patients $199/mo for the first 2 months
Tirzepatide / month
$299/moBrand Zepbound vial or KwikPen, 2.5 mg starting dose, visits billed separately
Index 77/100 · Grade CChecked October 2026
Check Knownwell pricing Read review

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Both score 77/100 on the Cost-Efficiency Index. There is no score winner; compare the treatment you need, billing terms and state availability.

Check the difference in state access

Alloy
48 states; compounded options restricted in 4 more states and DC
Knownwell
All 50 states

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Alloy

Knownwell

Semaglutide / month
Alloy: $169/moStarting dose, compounded
Knownwell: $149/moBrand Wegovy pill, 1.5 mg starting dose, visits billed separately; Wegovy pen $349/mo, new patients $199/mo for the first 2 months
Tirzepatide / month
Alloy: $199/moStarting dose, compounded
Knownwell: $299/moBrand Zepbound vial or KwikPen, 2.5 mg starting dose, visits billed separately
Semaglutide / year (modeled)
Alloy: $2,028
Knownwell: $1,788
Tirzepatide / year (modeled)
Alloy: $2,388
Knownwell: $3,588
State availability
Alloy: 48 states; compounded options restricted in 4 more states and DC
Knownwell: All 50 states
Oral / sublingual option listed
Alloy: Yes
Knownwell: Yes
Brand-name access listed
Alloy: Yes
Knownwell: Yes
Provider facts checked
Alloy: October 2026
Knownwell: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Alloy

Women who want menopause care and GLP-1 weight management under the same physician and don't mind a recurring care fee.

Reasons to consider it

  • Brand and compounded medication options are listed with published starting prices
  • The $99 care fee includes physician messaging, dose adjustments and delivery
  • Menopause-trained physicians can coordinate weight care with hormone therapy

What to weigh up

  • Medication starting prices exclude the $99 monthly care fee; the ongoing combined floor is $169 for compounded semaglutide and $199 for compounded tirzepatide
  • The first-month care discount applies once; month two returns to the full $99 fee
  • Weight care excludes Louisiana and Mississippi; compounded options also exclude Alabama, Arkansas, California, Nevada and DC

Compounded drugs are not FDA-approved. Understand the medication options.

Check Alloy pricing Read the full Alloy review

Knownwell

Insured shoppers who want an obesity-medicine specialist overseeing brand-name GLP-1 care, with published self-pay drug prices as a fallback.

Reasons to consider it

  • Co-founded and clinically led by Dr. Angela Fitch, a named, credentialed obesity-medicine specialist (Chief Medical Officer)
  • Prescribes branded FDA-approved GLP-1s across the current class (Wegovy, Zepbound, Ozempic, Saxenda) plus orforglipron/Foundayo
  • Publishes a self-pay price for every drug and dose, from $149 a month for the Wegovy pill

What to weigh up

  • Brand-name only, and the price rises with the dose: the Wegovy pill runs $149 to $299 a month, the Wegovy pen $349, and Zepbound $299 to $449
  • Those are medication prices; without insurance, knownwell's own visits cost $299 for the first and $149 for each follow-up
  • In-person care is limited to five states (Texas has primary care in Plano only), so most of the country can only use the virtual clinic
Check Knownwell pricing Read the full Knownwell review

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

AlloyKnownwell
Normalized Cost/Month
Alloy:
71/100
Knownwell:
73/100
Price Transparency
Alloy:
78/100
Knownwell:
72/100
Nationwide Access
Alloy:
78/100
Knownwell:
86/100
Formulation Options
Alloy:
95/100
Knownwell:
95/100
Clinical Oversight
Alloy:
87/100
Knownwell:
82/100
Contract Flexibility
Alloy:
55/100
Knownwell:
55/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Alternatives to AlloyAlternatives to Knownwell
More provider matchups
CoreAge Rx vs AlloyCoreAge Rx vs Knownwell
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.